KR20040101709A - Cosmetic composition containing camellia japonica extract stabilized with nanoliposome - Google Patents

Cosmetic composition containing camellia japonica extract stabilized with nanoliposome Download PDF

Info

Publication number
KR20040101709A
KR20040101709A KR1020030033413A KR20030033413A KR20040101709A KR 20040101709 A KR20040101709 A KR 20040101709A KR 1020030033413 A KR1020030033413 A KR 1020030033413A KR 20030033413 A KR20030033413 A KR 20030033413A KR 20040101709 A KR20040101709 A KR 20040101709A
Authority
KR
South Korea
Prior art keywords
skin
extract
camellia
stabilized
cosmetic composition
Prior art date
Application number
KR1020030033413A
Other languages
Korean (ko)
Inventor
김광수
황지일
이승화
Original Assignee
나드리화장품주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나드리화장품주식회사 filed Critical 나드리화장품주식회사
Priority to KR1020030033413A priority Critical patent/KR20040101709A/en
Publication of KR20040101709A publication Critical patent/KR20040101709A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a cosmetic composition which comprises the extract of Camellia japonica stabilized in nanoliposome for preventing skin-aging. The cosmetic composition whitens skin and improves moisturization and skin elasticity to prevent skin-aging. CONSTITUTION: The cosmetic composition comprises, as an active ingredient, 0.1-20 wt.% of the extract of Camellia japonica which is obtained by supercritical extraction and stabilized in nanoliposome, wherein the extract of Camellia japonica is contained in the nanoliposome in the amount of 10-40 wt.%.

Description

동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물{COSMETIC COMPOSITION CONTAINING CAMELLIA JAPONICA EXTRACT STABILIZED WITH NANOLIPOSOME}Cosmetic composition containing nanoliposomes stabilized camellia extract {COSMETIC COMPOSITION CONTAINING CAMELLIA JAPONICA EXTRACT STABILIZED WITH NANOLIPOSOME}

본 발명은 동백나무 추출물을 함유하는 화장료 조성물에 관한 것으로, 특히 초임계 추출법으로 얻어진 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a camellia extract, and more particularly to a cosmetic composition containing a nanoliposome stabilized camellia extract obtained by the supercritical extraction method.

최근 들어 여성들의 화장품의 기능에 대한 욕구가 높아짐에 따라, 화장품의 기본 기능인 청결 및 미적 기능뿐만 아니라, 미백 효과, 피부의 주름 개선 및 억제 효과 등의 노화 방지 효과를 가진 고기능성 제품이 등장하게 되었다.Recently, as women's desire for the function of cosmetics has increased, high-functional products having anti-aging effects such as whitening effects, wrinkle improvement and suppression of skin, as well as clean and aesthetic functions, which are basic functions of cosmetics, have emerged. .

피부 노화 메카니즘은 어느 한 학설로 설명되어지는 것이 아니다. 이미 밝혀진 연구결과나 진행중인 연구결과에 따르면, 성장기가 멈춘 시가의 피부를 왕성한 상태의 피부구조재구축에 의하여 재생하는 것은 거의 불가능에 가깝지만, 이미생성된 주름에 대해서는 보다 적극적인 개선이 가능하여, 보다 탄력적이고 매끄러운 피부로 가꿀 수 있는 것으로 밝혀지고 있다.The mechanism of skin aging is not explained by any one theory. According to the findings and ongoing research, it is almost impossible to regenerate the skin of cigars with growing growth by rebuilding the skin in a healthy state, but it is possible to make more active improvement on the already created wrinkles, making it more elastic and It turns out that you can get smooth skin.

이와 관련하여, 미국특허 제5,340,568호에는, 성장인자와 유사한 기능을 하며 세포증식을 유도하는 2-데옥시-2-할로-리조포스파티딕산(2-Deoxy-2-halo-lysophosphatidic acid)을 함유한 조성물이 피부주름 생성을 억제하는 것으로 기재되어 있고, WO 94/04184에는 단백질성장인자를 안정화시킨 조성물이 피부주름, 피부의 처짐 등의 피부노화 현상을 방지하며, 상기 단백질 성장인자로는 표피 성장인자(Epidermal growth factor : EGF), 인슐린 유사 성장인자(Insulin-like growth factor : IGF), 혈소판 유래 성장인자(Platelet-derived growth factor : PDGF), 섬유아세포 성장인자(Fibroblast growth factor : FGF) 등이 있는 것으로 기재되어 있다.In this regard, US Pat. No. 5,340,568 contains 2-Deoxy-2-halo-lysophosphatidic acid, which functions similar to growth factors and induces cell proliferation. One composition is described as inhibiting the production of skin wrinkles, WO 94/04184 describes a composition in which protein growth factors are stabilized to prevent skin aging such as skin wrinkles, sagging of the skin, epidermal growth as a protein growth factor Factor (Epidermal growth factor, EGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) It is described as being.

그러나, 상기 피부 주름개선 유효성분들은, 일부 화장품 원료로 사용할 수 없거나 매우 불안정하며, 피부로의 전달이 용이하지 않아 특별한 안정화시스템과 전달체계가 필요하고, 피부주름의 개선효과가 가시적이지 않는 등의 문제점이 있다.However, the skin wrinkle improvement active ingredients, which can not be used as a cosmetic raw material or very unstable, it is not easy to transfer to the skin requires a special stabilization system and delivery system, such as the improvement effect of the skin wrinkles is not visible There is a problem.

이에 따라, 최근 레티노이드를 함유한 피부보호제에 대해 관심이 점차 집중되고 있으며, 현재 레티노이드는 일광으로 축적된 결과인 주름살, 피부의 두꺼워짐, 처짐, 탄력 감소 등의 광노화 현상을 해결하는 수단으로 이용되고 있다. 그러나, 레티노이드는 매우 불안정한 화합물로, 빛(자외선), 수분, 열, 공기(산소)에 민감하여 쉽게 화학적인 변화를 일으키는 문제점이 있다.Accordingly, attention has recently been focused on skin protection agents containing retinoids. Currently, retinoids are used as a means to solve photoaging phenomena such as wrinkles, skin thickening, sagging and elasticity, which are the result of daylight accumulation. have. However, retinoids are very unstable compounds, which are susceptible to light (ultraviolet light), moisture, heat, air (oxygen) and easily cause chemical changes.

또한, 레티놀과 레티노익산과 같이 주름개선 효과가 높은 물질도 화학적 불안정성, 사용상의 난이성, 제형기술의 복잡성 및 피부 자극성 등으로 인해 화장료의 원료로 이용하기에 어려우며, 레티닐 팔미테이트나 레티닐 아세테이트 등의 레티닐 에스테르와 비타민 A의 전구물질인 β-카로틴은 주름개선효과는 낮지만, 사용의 간편성, 안전성이 높아 화장품의 원료로 많이 이용되고 있는 실정이다.In addition, materials with high antiwrinkle effects, such as retinol and retinoic acid, are difficult to use as raw materials for cosmetics due to chemical instability, difficulty in use, complexity of formulation technology, and skin irritation, such as retinyl palmitate or retinyl acetate. Β-carotene, a precursor of retinyl ester and vitamin A, has a low anti-wrinkle effect, but is widely used as a raw material for cosmetics due to its ease of use and high safety.

비타민 C에 대해서도, 인체의 노화현상과 관련하여 가장 강력한 항 산화제로서 인정받고 있으나, 그 안정성의 문제에 의해 화장료로의 사용이 어려워 비타민 C 자체가 아닌 여러 유도체를 사용하고 있는 현실이다.Vitamin C is also recognized as the most powerful antioxidant in relation to the aging of the human body, but due to its stability, it is difficult to use as a cosmetic because of the fact that many derivatives are used instead of vitamin C itself.

동백나무(Camellia Japonica)는 상록활엽수 교목으로, 휜 줄기에서 잔가지가 많이 나와 장 타원형 또는 반 구형의 수형을 이루며, 수피는 회백색으로 평활하고, 잎은 어긋나고 타원형 또는 긴 타원형으로 잔 톱니가 있다. 길이 5∼12㎝, 넓이 3∼7㎝로 표면은 짙은 녹색이다. 성분으로는 씨에 기름이 66% 존재하며 그 주성분은 올레익산의 글리세라이드이다. 또한, 씨에 배당체 카멜린(C18H34O7), 카멜리아 사포닌(C58H92O25)이 존재한다(약초의 성분과 이용). 카멜린은 강심작용이 있고, 카멜리아 사포닌은 용혈작용이 알려져 있는 것으로 알려져 있으며, 동백기름은 유성연고 기초제로 쓰이고, 동백나무꽃은 민간에서 장출혈, 자궁출혈, 토혈 등에 피 멎이 약으로 쓰인다.Camellia Japonica is an evergreen broad-leaved arboreous tree, with many twigs on the stem of long roots, long oval or semi-spherical, with bark smooth gray, leaves alternate, oval or long oval. It is 5-12cm long and 3-7cm wide, and its surface is dark green. There is 66% oil in the seed and its main ingredient is glyceride of oleic acid. In addition, glycosides camellia (C18H34O7) and camellia saponin (C58H92O25) are present in the seeds (components and use of herbs). Camellia has a strong action, Camellia saponin is known to be known for hemolytic action, camellia oil is used as a base oil-based ointment, camellia flowers are used in the intestinal bleeding, uterine bleeding, hemorrhage, etc. as a medicine.

초임계 유체 추출 기술은, 특정 물질이 일정한 고압 및 고온(임계점)을 넘어서면 유체 상태가 되는데, 이 상태의 특정 물질을 용매로 사용하여 독성이나 잔류 물질 없이 인간에게 이로운 유효 성분만을 고순도로 분리, 정제해 내는 기술이다.이러한 용매로서의 초임계 유체는, 임계온도(critical temperature, Tc)와 임계압력(critical pressure, Pc) 부근 또는 그 이상의 상태로 사용되며, 일반적으로 사용되는 초임계 유체로는 임계온도가 낮아 열에 불안정한 물질의 분리 정제에 용이한 이산화탄소를 들 수 있다. 이와 같은 초임계 유체 용매인 이산화탄소를 사용하면, 일반적인 용매 대신 인체에 무해한 이산화탄소를 이용하므로 피부에 무독성이고, 제품으로부터 쉽게 제거가능하므로 유기용매 추출시에 문제가 되는 환경오염을 방지할 수 있으며, 가격이 저렴하고, 추출과정을 최대한 단순화함으로써 생화학적 안정성(산소차단, 미생물 오염방지)을 얻을 수 있다.Supercritical fluid extraction technology is a fluid state when a certain material exceeds a certain high pressure and high temperature (critical point), using the specific material as a solvent to isolate only the active ingredients with high purity, which are beneficial to humans, without toxic or residual substances. The supercritical fluid as a solvent is used at or near the critical temperature (Tc) and the critical pressure (Pc), and as a commonly used supercritical fluid, the critical Carbon dioxide which is easy to isolate | separate and refine | purify a material which is low in temperature with low temperature is mentioned. By using carbon dioxide, a supercritical fluid solvent, it is non-toxic to skin because it uses carbon dioxide that is harmless to the human body instead of the general solvent, and can be easily removed from the product, thereby preventing environmental pollution, which is a problem when extracting an organic solvent. This inexpensive and simplifies the extraction process as much as possible to achieve biochemical stability (oxygen blocking, microbial contamination).

본 발명은, 노화방지 유효성분을 최대한 추출하여 노화방지 효과가 뛰어나고, 나노리포좀 안정화를 통하여 생체이용률이 우수한, 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물을 얻는 것을 목적으로 한다.An object of the present invention is to obtain a cosmetic composition containing nanoliposomes stabilized camellia extract, excellent anti-aging effect, and excellent in bioavailability through nanoliposome stabilization by extracting the anti-aging active ingredient as much as possible.

도 1은 시험예 2에 따른 세포증식능을 나타낸 그래프,1 is a graph showing the cell proliferation ability according to Test Example 2,

도 2는 시험예 3에 따른 콜라겐 생합성을 나타낸 그래프.2 is a graph showing collagen biosynthesis according to Test Example 3.

따라서, 본 발명에 따르면, 초임계 추출법에 의한 동백나무 추출물을 포함하는 나노리포좀을 화장료 조성물 총 중량에 대하여 0.1 ~ 20 중량% 함유하는 것을 특징으로 하는, 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료조성물이 제공된다.Therefore, according to the present invention, the nanoliposomes comprising the Camellia extract by the supercritical extraction method, characterized in that it contains 0.1 to 20% by weight based on the total weight of the cosmetic composition, containing the nanoliposomes stabilized Camellia extract A cosmetic composition is provided.

본 발명을 상세히 설명하면 다음과 같다.The present invention is described in detail as follows.

본발명에 따른 동백나무의 사용가능한 부위는 수피, 종자, 잎, 열매이며, 수피를 사용하는 것이 효과 면에서 바람직하다.The usable part of the camellia according to the present invention is bark, seed, leaf, fruit, and the use of bark is preferable in view of effect.

동백나무 추출물을 제조하기 위해서는, 먼저 동백나무를 건조시킨 후 분쇄하여 동백나무 분말을 제조한다.In order to prepare a camellia extract, first the camellia is dried and then pulverized to produce a camellia powder.

추출 용매로는, 1,3-부틸렌 글리콜과 에탄올을 같은 질량비로 혼합한 후 교반하여 단일상이 되도록 하고, 이를 공용매로 사용한다.As the extraction solvent, 1,3-butylene glycol and ethanol are mixed in the same mass ratio, followed by stirring to form a single phase, which is used as a cosolvent.

본 발명에 사용되는 초임계 유체 추출은 이산화탄소를 이용한 통상적인 방법으로 실시할 수 있으며, 구체적으로 다음과 같이 실시하는 것이 바람직하다.Supercritical fluid extraction used in the present invention can be carried out by a conventional method using carbon dioxide, specifically, it is preferably carried out as follows.

분쇄된 동백나무와 공용매를 혼합하여 교반한다. 혼합 비율은 동백나무와 공용매를 1:1 ~ 1:3의 질량비로 혼합하는 것이 바람직하며, 1:2의 질량비로 혼합하는 것이 수율 면에서 가장 우수하다. 이어서, 이 혼합물을 초임계 추출조에 투입하고, 고압용 기체펌프를 이용하여 추출조에 이산화탄소를 공급한 후 압력을 높인다. 이어서, 추출조 내부의 온도를 40℃ 까지 승온시키고 이를 유지시킨다. 그리고나서, 이산화탄소를 추출조에 연속적으로 공급하면서, 출구 쪽에 부착된 압력조절기를 이용하여 추출물을 방출시킨다. 압력조절기의 온도를 조절하여, 방출물의 압력 및 온도강하로 인해 이산화탄소가 고체 드라이아이스로 전이되어 최종 출구쪽의 튜브가 막히는 현상을 방지한다. 방출된 추출물은 상압으로 감압되어 이산화탄소와 동백나무 추출물이 분리되며, 이산화탄소는 대기로 방출되고 동백나무 추출물은 회수된다.The pulverized camellia and cosolvent are mixed and stirred. The mixing ratio is preferably a mixture of camellia and cosolvent in a mass ratio of 1: 1 to 1: 3, and mixing in a mass ratio of 1: 2 is the best in terms of yield. Subsequently, the mixture is introduced into a supercritical extraction tank, and carbon dioxide is supplied to the extraction tank using a high pressure gas pump to increase the pressure. Then, the temperature inside the extraction tank is raised to 40 ° C. and maintained therein. Then, while continuously supplying carbon dioxide to the extraction tank, the extract is released using a pressure regulator attached to the outlet side. By controlling the temperature of the pressure regulator, the pressure and temperature drop of the discharge prevent carbon dioxide from transferring to solid dry ice and clogging the tube at the final outlet. The released extract is decompressed to atmospheric pressure to separate the carbon dioxide and Camellia extract, the carbon dioxide is released into the atmosphere and the Camellia extract is recovered.

이와 같이 얻어진 동백나무 추출물을 안정화시켜 피부 침투가 용이하도록 하기 위하여 나노리포좀에 함유시킨다.The Camellia extract thus obtained is contained in the nanoliposomes in order to stabilize the camellia.

본 발명에서의 나노리포좀은, 인지질, 글루타치온, 폴리솔베이트20, 에탄올로 구성되는 리포좀을 고압유화장치에 7회 통과시켜 크기를 작게 한 것을 사용한다.The nanoliposome in the present invention uses a liposome consisting of phospholipid, glutathione, polysorbate 20, and ethanol seven times through a high pressure emulsifying device to reduce its size.

이 때, 상기 동백나무 추출물은 추출물 함유 나노리포좀의 총 중량에 대하여 10~40 중량%로 첨가한다. 10 중량% 미만으로 첨가하면 효과를 기대하기 힘들고, 40 중량%를 초과하면 함량이 증가해도 뚜렷한 효능 효과의 상승이 보이지 않는다.At this time, the Camellia extract is added in 10 to 40% by weight based on the total weight of the extract-containing nanoliposomes. If it is added less than 10% by weight, the effect is hard to expect, and if it exceeds 40% by weight, no significant increase in efficacy effect is seen.

얻어진 동백나무 추출물을 안정화시킨 나노리포좀은, 영양 화장수, 영양크림, 에센스 등의 보습 화장료에 첨가할 수 있으며, 특히 액상 또는 투명 화장료에 첨가할 수 있다.The nanoliposomes obtained by stabilizing the obtained Camellia extract can be added to moisturizing cosmetics such as nourishing lotion, nourishing cream and essence, and in particular can be added to liquid or transparent cosmetics.

동백나무 추출물을 안정화 시킨 나노리포좀은, 조성물 총 중량에 대하여 0.1 ~ 20 중량%로 첨가하는 것이 바람직하고, 1 ~ 10 중량%가 더욱 바람직하다. 0.1 중량% 미만이면 유효한 효과를 기대하기 힘들고, 20 중량%를 초과하면 함량이 증가해도 뚜렷한 효능의 상승이 나타나지 않는다.Nanoliposomes stabilized camellia extract is preferably added in an amount of 0.1 to 20% by weight, more preferably 1 to 10% by weight based on the total weight of the composition. If it is less than 0.1% by weight, it is difficult to expect an effective effect. If it exceeds 20% by weight, there is no apparent increase in efficacy even if the content is increased.

이하 실시예 및 비교예, 제조예, 시험예는 본 발명을 더욱 상세하게 설명하기 위한 것으로, 본 발명의 권리 범위가 이들에 의해 제한되는 것은 아니다.The following Examples, Comparative Examples, Preparation Examples, and Test Examples are provided to explain the present invention in more detail, and the scope of the present invention is not limited thereto.

(실시예 1)(Example 1)

동백나무 추출물의 제조Preparation of Camellia Extract

동백나무 수피를 중량의 변화가 없을 때까지 건조시키고, 분쇄기를 이용하여 직경 0.3cm 이하의 크기로 분쇄하였다. 또한, 1,3-부틸렌글리콜과 에탄올을 같은 질량비율로 혼합한 후 교반시켜 단일상의 공용매를 제조하였다.Camellia bark was dried until there was no change in weight, and ground to a size of 0.3 cm or less using a grinder. In addition, 1,3-butylene glycol and ethanol were mixed in the same mass ratio and stirred to prepare a single-phase cosolvent.

분쇄된 동백나무 수피와 공용매를 1:2의 질량비로 혼합하여 30분간 교반시킨후, 혼합물을 내부 용적 1.5ℓ의 초임계 추출조에 투입하고 추출조를 밀봉하였다. 고압용 기체펌프를 이용하여 추출조에 이산화탄소를 공급하고 압력을 높인 뒤, 추출조의 압력을 높였다.The crushed camellia bark and the cosolvent were mixed at a mass ratio of 1: 2, stirred for 30 minutes, and then the mixture was put into a supercritical extraction tank having an internal volume of 1.5 L and the extraction tank was sealed. The high pressure gas pump was used to supply carbon dioxide to the extraction tank and increase the pressure, thereby increasing the pressure of the extraction tank.

PID 온도제어기를 이용하여 추출조 외부를 감싸고 있는 열선을 이용하여 추출조 내부의 온도를 0.5 /min 속도로 40℃ 까지 승온하여 50분간 유지시켰다.The temperature inside the extraction tank was raised to 40 ° C. at a rate of 0.5 / min and maintained for 50 minutes using a heating wire wrapped outside the extraction tank using a PID temperature controller.

다시 이산화탄소를 추출조에 연속적으로 공급하면서 추출물을 방출시켰다. 방출된 추출물은 상압으로 감압되어 이산화탄소와 수피추출물이 분리되었고 이산화탄소는 대기로 방출되었다. 분리된 수피 추출물을 유리 포집기를 이용하여 회수하였다.The extract was released while continuously supplying carbon dioxide to the extraction tank. The extracted extract was decompressed to atmospheric pressure to separate carbon dioxide and bark extract and carbon dioxide was released into the atmosphere. The separated bark extract was recovered using a glass collector.

(시험예 1)(Test Example 1)

섬유아세포 증식능 비교실험Fibroblast Proliferation Capacity Comparison Experiment

실시예 1의 동백나무 추출물을 사용하여, 사람 피부 유래 섬유 아세포를 이용한 세포 증식을 실험하였다. 섬유 아세포는 액체질소에 보관된 세포를 증식시켜 사용하였다. T-75 플라스크에서 배양한 섬유아세포를 PBS로 2-3회 세척하고, 트립신을 이용하여 부착된 세포를 떨어뜨린 후, 1500rpm에서 5분간 원심분리(Heraeus, Labofuge 400R)하여 세포를 모았다. 원심분리 후 상층액은 버리고, 침전세포에 10㎖의 DMEM(10% FBS)을 첨가하여 고르게 섞었다. 혈구 계수기를 이용하여 세포수를 측정하여 104ea/웰 정도의 세포를 96 웰의 각 웰에 200㎕씩 분주하였다. 37℃, 5% CO2에서 배양하면서 웰 면적의 약 50 %정도의 세포가 자라면 새로운 DMEM(FBS10%)으로 배지를 교환해 주면서, 실시예 1의 동백나무 추출물을 농도별(0.00001%, 0.0001%, 0.001%, 0.01%, 0.1%, 1%)로 첨가하여, 48시간동안 세포를 배양하였다.Using the Camellia extract of Example 1, cell proliferation using human skin-derived fibroblasts was tested. Fibroblasts were used to proliferate cells stored in liquid nitrogen. Fibroblasts cultured in T-75 flasks were washed 2-3 times with PBS, and the adherent cells were dropped using trypsin, followed by centrifugation at 1500 rpm for 5 minutes (Heraeus, Labofuge 400R) to collect the cells. After centrifugation, the supernatant was discarded, and 10 ml of DMEM (10% FBS) was added to the precipitated cells and mixed evenly. By measuring the number of cells using a blood cell counter 4 to 10 ea / well degree of cell to each well of a 96 well it was dispensed by 200㎕. When the cells of about 50% of the well area were grown while incubating at 37 ° C. and 5% CO 2 , the camellia extract of Example 1 was changed by concentration (0.00001%, 0.0001) while replacing the medium with fresh DMEM (FBS10%). %, 0.001%, 0.01%, 0.1%, 1%), cells were incubated for 48 hours.

MTT{(3-(4,5-디메틸티아졸-2-일)-2,5-디페닐 테트라졸륨 브로마이드(Sigma)}를 PBS에 2㎎/㎖가 되도록 용해시켜 냉장고에 보관해서 사용하였으며, 각 웰에 MTT시약(5㎎/㎖ in PBS)을 20㎕씩 처리하고, 2시간 더 배양한 후 상등액을 버리고 0.04N-HCl 100㎕를 넣고 섞어주었다. 모든 단계가 끝난 후 ELISA 판독기(μQuant, Bio-Tek instrument INC.)를 이용해 560nm에서 흡광도를 측정하였다(Reference : 650nm).MTT {(3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide (Sigma)} was dissolved in PBS to 2 mg / ㎖ was stored in the refrigerator and used Each well was treated with 20 μl of MTT reagent (5 mg / ml in PBS), incubated for 2 more hours, discarded the supernatant, and mixed with 100 μl of 0.04 N-HCl, followed by ELISA reader (μQuant, Absorbance was measured at 560 nm using Bio-Tek instrument INC. (Reference: 650 nm).

세포증식능을 다음 식에 따라 계산하여, 그 결과를 도 1에 나타내었다.Cell proliferation was calculated according to the following equation, and the results are shown in FIG. 1.

도 1에서, 실시예 1의 동백나무 추출물은, 무처리구는 40% 정도인 데 반해 처리구 0.01%에서 48시간 후에 85%정도의 세포 증식효과를 보였다.In Fig. 1, the Camellia extract of Example 1 showed a cell proliferation effect of about 85% after 48 hours at 0.01% of the treatment, while the treatment-free treatment was about 40%.

(시험예 2)(Test Example 2)

콜라겐 생합성 효과Collagen Biosynthesis Effect

T-75 플라스크에 배양되어진 섬유아세포를 PBS로 2∼3회 세척하고, 트립신을 이용하여 부착된 세포를 떨어뜨린 후, 1500rpm에서 5분간 원심분리(Heraeus; Labofuge 400R)하여 세포를 모았다. 원심분리 후 상층액은 버리고, 모아진 세포에 10㎖의 DMEM(10% FBS)을 첨가하여 고르게 섞었다. 혈구계수기를 이용하여 세포수를 측정하여 104ea/웰 정도의 세포를 96웰의 각 웰에 200㎕씩 분주하였다. 37℃, 5%CO2에서 배양하면서 웰 면적의 약 50%정도의 세포가 자라면 새로운 DMEM(FBS 10%)으로 교환해 주면서, 실시예 1의 동백나무 추출물을 농도별(0.00001%, 0.0001%, 0.001%, 0.01%, 0.1%, 1%)로 첨가하여, 48시간동안 세포를 배양하였다.Fibroblasts incubated in T-75 flasks were washed 2-3 times with PBS, the adhered cells were dropped using trypsin, and the cells were collected by centrifugation (Heraeus; Labofuge 400R) at 1500 rpm for 5 minutes. After centrifugation, the supernatant was discarded, and 10 ml of DMEM (10% FBS) was added to the collected cells and mixed evenly. By measuring the number of cells using a hemocytometer, cells of about 10 4 ea / well were dispensed into each 200-well well of 96 wells. When incubating at 5% CO 2 at 37 ° C and growing about 50% of the well area, the Camellia extract of Example 1 was changed by concentration (0.00001%, 0.0001%) while exchanging with fresh DMEM (FBS 10%). , 0.001%, 0.01%, 0.1%, 1%), and the cells were incubated for 48 hours.

콜라겐 합성능 측정키트 (Procollagen Type-I C-peptide EIA kit (Takara, MK 101))를 사용하였다. 면역학적 방법을 이용한 측정법을 위하여 100㎕의 Ab-POD 컨쥬게이트 용액을 하나의 웰에 옮겨 분주하고, 20㎕의 세포배양액 또는 표준용액을 첨가하였다. 호일로 96 웰 플레이트를 싸서 37℃에서 3시간 정도 배양하였다. 3시간 경과 후 각 웰에 들어있는 용액을 모두 제거하고 PBS로 4번정도 세척하였다. 세척 단계 후에 100㎕의 기질용액을 각 웰에 첨가하여 20∼30℃에서 15분간 배양하였다. 최종 단계로 반응종료 용액인 1N H2SO4를 100㎕ 첨가하여 부드럽게 혼합하였다. ELISA 판독기로 흡광도를 측정하여 그 결과를 사용하였다. 반응종료용액이 첨가되된 플레이트를 약 1시간 정도 실온에서 보관한 후 450nm에서 흡광도를 측정하였다.Collagen synthesis performance measurement kit (Procollagen Type-I C-peptide EIA kit (Takara, MK 101)) was used. For determination using immunological methods, 100 μl of Ab-POD conjugate solution was transferred to one well and aliquoted, and 20 μl of cell culture or standard solution was added. A 96 well plate was wrapped in foil and incubated at 37 ° C. for about 3 hours. After 3 hours, all the solutions in each well were removed and washed 4 times with PBS. After the washing step, 100 μl of substrate solution was added to each well and incubated at 20-30 ° C. for 15 minutes. In the final step, 100 µl of 1N H 2 SO 4 , the reaction termination solution, was added and mixed gently. The absorbance was measured with an ELISA reader and the result was used. After the reaction solution was added, the plate was stored at room temperature for about 1 hour and absorbance was measured at 450 nm.

합성(%)를 다음 식에 따라 계산하여, 그 결과를 도 2에 나타내었다.Synthesis (%) was calculated according to the following equation, and the results are shown in FIG. 2.

도 2에서, 세포증식능의 결과와 마찬가지로 그 증강효과가 크게 나타남을 알 수 있다.In Figure 2, it can be seen that as shown in the results of cell proliferation, the enhancement effect is large.

(시험예 3)(Test Example 3)

멜라닌 생성 저해 효과Melanin production inhibitory effect

실시예 1의 동백나무수피 추출물을 이용하여 멜라닌 생성량 억제 효과를 실험하였다.The inhibitory effect of melanin production was tested using the Camellia bark extract of Example 1.

인체 조직으로부터 분리한 멜라닌 세포를 1차 배양하여 2계대 후, 60㎜ 배양 접시에서 RPMI 1640 배지를 사용하여 2×104세포/배양접시의 농도로 배양하였다. 세포가 접시에 부착한 것을 확인한 후, 동백나무 추출물을 0.001, 0.01, 0.1, 1%까지 농도별로 처리하였다. 처리한 3일 후, 트립신-EDTA로 세포를 떼어내어 2×105세포를 일정하게 분배하였다. 여기에 100㎕의 1N NaOH 용액을 넣고 37℃에서 12시간 처리하여 세포를 완전히 용해시켰다. 세포가 완전히 용해된 시료 500㎕에 대하여 490nm에서 흡광도를 측정하였다. 또한 추출물 무처리구를 대조구로 하여 흡광도를 측정하였다.Melanocytes isolated from human tissues were primaryly cultured and passaged two times, and then cultured in 60 mm culture dishes at a concentration of 2 × 10 4 cells / culture plate using RPMI 1640 medium. After confirming that the cells attached to the dish, camellia extract was treated by concentration up to 0.001, 0.01, 0.1, 1%. After 3 days of treatment, cells were detached with trypsin-EDTA and the 2 × 10 5 cells were evenly distributed. 100 μl of 1N NaOH solution was added thereto and treated at 37 ° C. for 12 hours to completely lyse the cells. Absorbance was measured at 490 nm for 500 μl of cells in which cells were completely lysed. In addition, absorbance was measured using the extract-free treatment as a control.

표준 지표로, 합성 멜라닌(M8601, 시그마사제) 10㎎을 1N NaOH 10㎖에 녹여 모용액(1㎎/㎖)을 제조한 후, 700㎍/㎖, 300㎍/㎖, 100㎍/㎖, 70㎍/㎖, 30㎍/㎖, 10㎍/㎖, 7㎍/㎖, 3㎍/㎖, 1㎍/㎖, 0.1㎍/㎖, 0㎍/㎖의 희석액을 제조하여 490nm에서 흡광도를 측정하였다. 하기 식에 따라 멜라닌 감소량을 계산하였다As a standard indicator, 10 mg of synthetic melanin (M8601, manufactured by Sigma Co., Ltd.) was dissolved in 10 ml of 1N NaOH to prepare a mother solution (1 mg / ml), followed by 700 µg / ml, 300 µg / ml, 100 µg / ml, 70 Dilutions of μg / ml, 30 μg / ml, 10 μg / ml, 7 μg / ml, 3 μg / ml, 1 μg / ml, 0.1 μg / ml and 0 μg / ml were prepared and the absorbance was measured at 490 nm. The amount of melanin reduction was calculated according to the following equation.

그 결과를 하기 표 1에 나타내었다.The results are shown in Table 1 below.

멜라닌 감소량Melanin reduction 동백나무 추출물(%)Camellia Extract (%) 멜라닌 감소량(%)Melanin Reduction (%) 1One 32.3532.35 0.10.1 46.0646.06 0.010.01 53.1253.12 0.0010.001 16.4216.42

표 1에 따르면, 동백나무 추출물은 멜라닌을 생합성하는 작용을 억제함으로써 미백의 효능도 나타냄을 알 수 있다.According to Table 1, camellia extract can be seen that the effect of whitening by inhibiting the action of biosynthesis melanin.

(비교예 1)(Comparative Example 1)

동백나무의 수피를 실온에서 중량의 변화가 없을 때까지 건조하였다. 이를 분쇄기로 분쇄하여 분말화하였다. 동백나무 수피 건조 분말 50g에 50g의 에탄올에 투입하여 약 60℃에서 약 48시간동안 중탕하였다. 찌꺼기를 제거한 추출액을 300메쉬의 여과지를 사용하여 일차 여과시키고, 그 여과된 추출액을 다시 0.40㎛ 여과지로 제균 여과하여 추출물을 얻었다.The bark of camellia was dried at room temperature until there was no change in weight. It was ground by pulverization to powder. 50 g of camellia bark dry powder was added to 50 g of ethanol, and the mixture was heated at about 60 ° C. for about 48 hours. The extract removed from the debris was first filtered using a 300 mesh filter paper, and the filtered extract was filtered again and again with 0.40 μm filter paper to obtain an extract.

(시험예 4)(Test Example 4)

활성산소 소거 능력 측정Free radical scavenging ability measurement

상기 실시예 1에서 얻은 초임계 동백나무 추출물과 비교예 1의 에탄올 동백나무 추출물에 대하여, 활성 산소 소거 능력을 갖는 물질인 카테친의 함량을 측정하였다. 활성 산소 종은 각종 성인병과 노화, 특히 피부노화 및 과색소침착의 원인이 되므로, 기능성 항주름 및 미백화장품에서는 이의 소거 능력은 필수적이다.For the supercritical camellia extract obtained in Example 1 and the ethanol camellia extract of Comparative Example 1, the content of catechin as a substance having active oxygen scavenging ability was measured. Since reactive oxygen species cause various adult diseases and aging, in particular, skin aging and hyperpigmentation, its scavenging ability is essential in functional anti-wrinkle and whitening cosmetics.

구체적으로, 실시예 1과 비교예 1의 동백나무 추출물, 카테친 표준품(Sigma제)을 각각 약 5.0mg씩 정밀하게 달아, 이동상 50㎖에 녹인 다음, 다시 이동상을 넣어 100㎖로 만들어 검액 및 표준액으로 하였다.Specifically, the Camellia extract of Example 1 and Comparative Example 1, catechin standard (manufactured by Sigma) were precisely weighed by about 5.0 mg each, dissolved in 50 ml of a mobile phase, and then added to the mobile phase to make 100 ml. It was.

검액 및 표준액 20㎕로 액체 크로마토그라피(1100Series, AT사)를 이용해 카테큐익산, 소포레틴의 피크면적 비율{QT(검액 면적)/Qs(표준품 면적)×100}를 구하였다.Test solution, and by using liquid chromatography (1100Series, AT, Inc.) as the standard solution was determined 20㎕ category cue acid, peak area ratios of the parcel retinoic {Q T (sample area) / Qs (standard size) × 100}.

상기 시험을 위한 액체 크로마토그라피의 조작 조건은 하기와 같다.The operating conditions of the liquid chromatography for the test are as follows.

이동상 : 인산 1.0g을 50% 메탄올 용액에 녹여 2ℓ로 만든다.Mobile phase: 1.0 g of phosphoric acid is dissolved in 50% methanol solution to make 2 liters.

검출기 : 자외부흡광광도계 (측정파장 280nm)Detector: UV absorbance photometer (wavelength 280nm)

컬럼 : C18 Column: C 18

유량 : 1.0㎖/분Flow rate: 1.0 ml / min

시험결과는 하기 표 2에 나타내었다.The test results are shown in Table 2 below.

시료sample 시험횟수Number of tests 카테친 함량(%)Catechin content (%) 평균Average 초임계 추출 동백나무수피 추출물Supercritical Extract Camellia Bark Extract 1One 95.095.0 94.9394.93 22 95.295.2 33 94.694.6 에탄올 동백나무 추출물Ethanol Camellia Extract 1One 31.531.5 30.7730.77 22 30.230.2 33 30.630.6

(시험예 5)(Test Example 5)

피부 보습 효과Skin moisturizing effect

나노리포좀화 이전의 단순 원료를 대상으로 피부 보습효과를 측정하기 위하여, 실시예 1의 동백나무 추출물과 비교 대상으로서 NMF(Natural Moisturizing Factor)의 구성성분인 Na-PCA(Sodium Pyrolidone Carboxylic acid), 콘드로이틴 황산나트륨(Na-Condroitin Sulfate), Na-하이알루로네이트 1% 수용액에 대하여 각각피부장벽기능의 표준 측정법인 장벽손상 후 경표피 수분 손실(TEWL) 감소를 측정하였다.In order to measure the skin moisturizing effect of simple raw materials before nanoliposomalization, Na-PCA (Sodium Pyrolidone Carboxylic acid), Chondroitin, which is a component of Natural Moisturizing Factor (NMF) as a comparison target with Camellia extract of Example 1 Na-Condroitin Sulfate and 1% aqueous solution of Na-hyaluronate were measured to reduce the epidermal moisture loss (TEWL) after barrier damage, which is a standard measure of skin barrier function.

구체적인 방법은 다음과 같다.The specific method is as follows.

8∼12주령된 무모생쥐 20마리의 배부에 피부장벽이 손상되도록 아세톤을 점적하였다. 경피수분손실량(TEWL: transepidermal water loss)이 4.0g/m2/h 에 도달하면 시료를 5cm2면적에 도포하였다. TEWL은 C-K(Courage+Khazaka, Cologne, Germany)사의 증발계(evaporimeter)인 Tewameter로 측정하였다. 도포 6시간 경과 후에 TEWL을 측정하여 TEWL이 감소되는 정도를 평가함으로써 피부장벽 기능이 회복되는 정도를 평가하였다.Acetone was instilled into the back of 20 hairless mice aged 8-12 weeks to damage the skin barrier. When transepidermal water loss (TEWL) reached 4.0 g / m 2 / h, the sample was applied to an area of 5 cm 2 . TEWL was measured with Tewameter, an evaporimeter from CK (Courage + Khazaka, Cologne, Germany). After 6 hours of application, TEWL was measured to evaluate the extent to which TEWL was reduced to evaluate the extent to which skin barrier function was restored.

효능평가에 사용된 회복율의 계산은 하기 식에 따라 계산하였다.The recovery rate used for the efficacy evaluation was calculated according to the following equation.

(단, Bt=6 : 피부장벽 손상 후 6시간 경과 후의 TEWL 측정값(Bt = 6: TEWL measured value 6 hours after skin barrier injury)

Bt=0 : 피부장벽 손상 이전의 TEWL 측정값Bt = 0: TEWL measurement before skin barrier injury

Bt=d : 피부장벽 손상 직후의 TEWL 측정값)Bt = d: TEWL measured immediately after skin barrier damage)

결과를 표 3에 나타내었다(단위는 ㎎/㎡/hr).The results are shown in Table 3 (unit: mg / m 2 / hr).

무모생쥐 번호Hairless Mouse Number 수피추출물(1%)Bark Extract (1%) Na-PCA수용액(1%)Na-PCA aqueous solution (1%) Na-CS수용액(1%)Na-CS aqueous solution (1%) Na-히알루로네이트수용액(1%)Na-hyaluronate aqueous solution (1%) 1One 1414 18.518.5 17.417.4 18.418.4 22 1616 1919 1818 1919 33 15.815.8 20.120.1 1919 19.219.2 44 17.617.6 2121 1919 19.619.6 55 13.513.5 20.520.5 2020 19.719.7 66 1313 18.518.5 2121 20.220.2 77 15.415.4 18.918.9 1818 20.320.3 88 15.215.2 18.318.3 19.319.3 21.421.4 99 17.117.1 18.818.8 1919 19.719.7 1010 14.514.5 20.320.3 1818 18.918.9 1111 13.913.9 17.417.4 18.218.2 18.618.6 1212 13.413.4 17.517.5 17.917.9 19.319.3 1313 15.915.9 19.819.8 1919 20.120.1 1414 15.115.1 18.818.8 17.617.6 21.121.1 1515 15.815.8 18.518.5 2020 19.819.8 1616 16.116.1 21.521.5 1818 18.618.6 1717 16.816.8 19.319.3 1818 1919 1818 17.017.0 19.119.1 19.519.5 19.219.2 1919 16.216.2 20.720.7 19.819.8 20.120.1 2020 16.616.6 19.519.5 20.220.2 20.120.1 평균측정수치Average measurement value 15.44515.445 19.319.3 18.84518.845 19.61519.615

상기 TEWL 측정 결과, 본 발명에 사용되는 동백나무 추출물은, 비교 검토 대상으로 사용된 Na-PCA(Sodium Pyrolidone Carboxylic acid)에 비해 19.97%, 콘드로이틴 황산나트륨(Na-Condroitin Sulfate)에 비해 18.04%, Na-히알루로네이트에 비해 21.26%정도 좋은 효과를 나타내었다.The TEWL measurement results, 19.97% compared to Na-PCA (Sodium Pyrolidone Carboxylic acid) used in the present invention, 18.04%, Na- compared to Na-Condroitin Sulfate 21.26% better than hyaluronate.

(실시예 2)(Example 2)

동백나무 추출물을 안정화시킨 나노리포좀의 제조Preparation of Nanoliposomes with Stabilized Camellia Extract

표 4의 A상을 95℃까지 가온하여 균일하게 혼합, 용해시켰다. 이를 40℃까지 냉각하여 B상을 넣고 혼합하였다. 이를 압력 1200 바, 유속 500m/s의 조건하에서 고압유화장치(Microfludizer M210EH, Microfluidies, USA)에 7회 통과시켜, 동백나무 추출물을 안정화시킨 나노리포좀을 얻었다. 1회 통과하여 얻은 리포좀의크기는 약 133nm이지만, 7회째의 크기는 약 75nm로 나타났다.Phase A in Table 4 was heated to 95 ° C., uniformly mixed and dissolved. It was cooled to 40 ° C and phase B was mixed. This was passed through a high pressure emulsifier (Microfludizer M210EH, Microfluidies, USA) seven times under a pressure of 1200 bar and a flow rate of 500 m / s to obtain a nanoliposome stabilized with Camellia extract. The size of the liposome obtained through one pass was about 133 nm, but the size of the seventh was about 75 nm.

원료명Raw material name 함량(중량%)Content (% by weight) AA 인지질Phospholipids 44 글루타치온Glutathione 0.10.1 95% 변성에탄올95% modified ethanol 2020 글리세린glycerin 3030 폴리솔베이트 20Polysorbate 20 44 BB 실시예 1의 동백나무 추출물Camellia Extract of Example 1 2020 정제수Purified water 잔량Remaining amount system 100100

(비교예 2)(Comparative Example 2)

동백나무 추출물을 첨가하지 않은 것을 제외하고는 실시예 2와 동일한 방법으로 나노리포좀을 제조하였다.Nanoliposomes were prepared in the same manner as in Example 2, except that Camellia extract was not added.

(제조예 1)(Manufacture example 1)

동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료의 제조Preparation of Cosmetics Containing Nanoliposomes Stabilizing Camellia Extract

하기 표 5의 원료를 사용하여, 통상적인 화장료의 제조 방법에 따라 에멀젼을 제조하였다.Using the raw materials shown in Table 5 below, an emulsion was prepared according to a conventional cosmetic preparation method.

원료명Raw material name 함량(단위: 중량%)Content (unit: weight%) 폴리솔베이트-60Polysorbate-60 1.51.5 소르비탄스테아레이탄Sorbitan stearaytan 0.50.5 스테아린산Stearic acid 1One 스쿠알란Squalane 55 세토스테아릴알콜Cetostearyl alcohol 22 세틸 옥타노에이트Cetyl octanoate 55 카보머Carbomer 0.150.15 트리에탄올 아민Triethanol amine 0.20.2 글리세린glycerin 55 실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀Nanoliposomes Stabilizing Camellia Extract of Example 2 0.10.1 incense 적당량A reasonable amount 방부제antiseptic 적당량A reasonable amount 정제수Purified water 잔량Remaining amount 총합total 100100

(비교제조예 1 내지 3)(Comparative Production Examples 1 to 3)

실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀을 사용하는 대신, Na-PCA, 콘드로이틴 황산나트륨, Na-하이알루로네이트 5 중량%를 각각 사용하는 것을 제외하고는, 제조예 1과 동일한 방법으로 에멀젼을 제조하고, 각각을 비교제조예 1 내지 3으로 하였다.Emulsion in the same manner as in Preparation Example 1, except that 5% by weight of Na-PCA, sodium chondroitin sulfate, and Na-hyaluronate were used instead of the nanoliposomes stabilized with the Camellia extract of Example 2. Were prepared, and each was made into Comparative Production Examples 1-3.

(비교제조예 4)(Comparative Production Example 4)

실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀을 사용하는 대신, 실시예 1의 동백나무 추출물 1 중량% 및 비교예 2의 나노리포좀 4 중량%를 사용하는 것을 제외하고는, 제조예 1과 동일한 방법으로 에멀젼을 제조하였다.Instead of using the nanoliposomes stabilized Camellia extract of Example 2, except that 1% by weight of Camellia extract of Example 1 and 4% by weight of nanoliposomes of Comparative Example 2 is used, the same as in Preparation Example 1 The emulsion was prepared by the method.

(비교제조예 5)(Comparative Production Example 5)

실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀을 사용하는 대신, 실시예 1의 동백나무 추출물 1 중량%를 사용하는 것을 제외하고는, 제조예 1과 동일한 방법으로 에멀젼을 제조하였다.An emulsion was prepared in the same manner as in Preparation Example 1, except that 1 wt% of the Camellia extract of Example 1 was used instead of the nanoliposomes stabilized Camellia extract of Example 2.

(제조예 2 내지 5)(Production Examples 2 to 5)

실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀을 각각 1, 5, 10, 20 중량% 첨가하는 것을 제외하고는 제조예 1과 동일한 방법으로 에멀젼을 제조하고, 각각 제조예 2 내지 5로 하였다.An emulsion was prepared in the same manner as in Preparation Example 1, except that 1, 5, 10, and 20 wt% of the liposomes stabilized the Camellia extract of Example 2 were added, respectively, to Preparation Examples 2 to 5.

(비교제조예 6 및 7)(Comparative Production Examples 6 and 7)

실시예 2의 동백나무 추출물을 안정화시킨 나노리포좀을 각각 0.05, 25 중량% 첨가하는 것을 제외하고는 제조예 1과 동일한 방법으로 에멀젼을 제조하고,각각 비교제조예 6 및 7로 하였다.An emulsion was prepared in the same manner as in Preparation Example 1, except that 0.05 and 25 wt% of the liposomes stabilized the Camellia extract of Example 2 were added, respectively, to Comparative Preparation Examples 6 and 7.

(시험예 6)(Test Example 6)

피부 탄력효과Skin elasticity effect

온도 22~24℃, 상대습도 55% 조건에서 20세 이상의 건강한 여성 60명(평균연령 29.5세)을 6 그룹으로 나누고, 제조예 3, 비교제조예 1 내지 5의 화장료 조성물을 각각 눈가를 중심으로 12주간 도포(2회/일)한 후, 피부탄력측정기(Cutometer SEM 575, C+K Electronic Co., Germany)를 이용하여 피부탄력을 측정하였다. 시험 결과는 하기 표 5에 Cutometer SEM 575의 각 시험 그룹별 평균값인 △R5값[R5(12주)-R5(0주)] 값으로 기재하였는데, R5 값은 실탄성 계수를 나타내는 값으로 1에 가까워지면 보다 탄력도가 우수함을 나타낸다.60 healthy women (average age 29.5 years old) of 20 years or older (mean age 29.5 years) were divided into 6 groups at the temperature of 22-24 degreeC and 55% of the relative humidity, and the cosmetic composition of manufacture example 3 and comparative manufacture examples 1-5 was centered around the eyes After application for 12 weeks (2 times / day), skin elasticity was measured using a skin elasticity measuring instrument (Cutometer SEM 575, C + K Electronic Co., Germany). The test results are described in Table 5 below as ΔR5 values (R5 (12 weeks) -R5 (0 weeks)), which are average values for each test group of the Cutometer SEM 575. The closer it is, the better the elasticity is.

또한 개선도는 하기 식에 의해 계산하였다.In addition, the improvement degree was computed by the following formula.

개선도(%) = ( △R5 / 도포전 ) X 100Improvement (%) = (△ R5 / Before Application) X 100

피부탄력도 측정실험결과(12주)Skin elasticity test result (12 weeks) 도포전Before application 도포후After application 피부탄력증강효과(△R5)Skin elasticity enhancing effect (△ R5) 개선도(%)% Improvement 제조예 3Preparation Example 3 0.740.74 1.121.12 0.380.38 51.3551.35 비교제조예 1Comparative Production Example 1 0.710.71 0.720.72 0.010.01 1.401.40 비교제조예 2Comparative Production Example 2 0.710.71 0.750.75 0.040.04 5.635.63 비교제조예 3Comparative Production Example 3 0.730.73 0.760.76 0.030.03 4.114.11 비교제조예 4Comparative Production Example 4 0.720.72 0.750.75 0.030.03 4.164.16 비교제조예 5Comparative Production Example 5 0.730.73 0.840.84 0.110.11 15.0715.07

상기 표 6에 따르면, 동백나무 추출물을 안정화시킨 나노리포좀을 함유한 제조예 3를 사용한 경우, 피부 탄력이 비교제조예 1에 비해 49.95%, 비교제조예 2에 비해 45.72%, 비교제조예 3에 비해 47.24%, 비교제조예 4에 비해 47.19%, 비교제조예 5에 비해 36.28% 증가했다. 따라서, 본 발명에 따른 동백나무 추출물을 안정화시킨 나노리포좀을 함유한 화장료는, NMF(Natural Moisturizing Factor)의 구성성분을 사용하거나 나노리포좀으로 안정화되지 않는 동백나무 추출물을 사용하는 경우보다, 피부탄력을 효과적으로 증진시킴을 알 수 있다.According to Table 6, when using Preparation Example 3 containing the nano-liposomes stabilized Camellia extract, skin elasticity is 49.95% compared to Comparative Preparation Example 1, 45.72% compared to Comparative Preparation Example 2, Comparative Preparation Example 3 47.24%, 47.19% compared to Comparative Preparation Example 4, 36.28% compared to Comparative Preparation Example 5. Therefore, cosmetics containing nanoliposomes stabilized camellia extract according to the present invention, skin elasticity than when using the components of the natural moisturizing factor (NMF) or camellia extract that is not stabilized with nanoliposomes Can be effectively promoted.

(시험예 7)(Test Example 7)

피부 수분량 측정Skin moisture measurement

22~24℃, 상대습도 55%, 공기의 흐름이 없는 실내에서 건강한 여성 70명(평균연령 29.5세)을 대상으로 각각 10명씩 7그룹으로 분리하였다. 제조예 1 내지 5 및 비교제조예 6 및 7의 화장료를 각 그룹마다 눈가를 중심으로 얼굴 전체에 하루 2회 6주간 도포하게 하였다. Skicon-200(IBS Co. Japan)을 이용하여, 도포 전, 후에 볼 부위의 수분량을 측정하여 보습효과의 지속성을 측정하였다. 그 결과를 하기 표 7에 각 시험그룹별 평균값으로 나타내었다.Seventy healthy women (mean age 29.5 years) were divided into seven groups of 70 healthy women (22 ~ 24 ℃, 55% relative humidity, no air flow). The cosmetics of Preparation Examples 1 to 5 and Comparative Preparation Examples 6 and 7 were applied to the entire face twice a day for 6 weeks, mainly around the eyes of each group. By using Skicon-200 (IBS Co. Japan), the moisture content of the cheek area was measured before and after application to measure the persistence of the moisturizing effect. The results are shown in Table 7 as an average value for each test group.

개선도는 다음 식에 따라 계산하였다.The improvement was calculated according to the following equation.

시험전Before the test 도포 6주 후6 weeks after application 개선도 (%)Improvement (%) 제조예 1Preparation Example 1 630 ± 10630 ± 10 645 ± 10645 ± 10 2.332.33 제조예 2Preparation Example 2 630 ± 10630 ± 10 690 ± 10690 ± 10 8.708.70 제조예 3Preparation Example 3 630 ± 10630 ± 10 850 ± 10850 ± 10 25.8825.88 제조예 4Preparation Example 4 630 ± 10630 ± 10 663 ± 10663 ± 10 4.984.98 제조예 5Preparation Example 5 630 ± 10630 ± 10 650 ± 10650 ± 10 3.083.08 비교제조예 6Comparative Production Example 6 630 ± 10630 ± 10 640 ± 10640 ± 10 1.561.56 비교제조예 7Comparative Production Example 7 630 ± 10630 ± 10 645 ± 10645 ± 10 2.332.33

상기 표에 따르면, 화장료 중에 안정화 시킨 나노리포좀을 0.1 내지 20 중량% 함유시키는 것이 바람직하다.According to the table, it is preferable to contain 0.1 to 20% by weight of stabilized nano-liposomes in cosmetics.

(시험예 8)(Test Example 8)

안정성 실험Stability experiment

본 발명에 따른 동백나무 추출물을 안정화시킨 나노리포좀을 함유한 화장료에 대한 제형의 안정성을 하기의 방법으로 측정하였다.Stability of the formulation for the cosmetic containing nanoliposomes stabilized Camellia extract according to the present invention was measured by the following method.

상기 제조예 3, 비교 제조예 4 및 5를 45℃로 일정하게 유지되는 항온조에서 불투명 초자 용기에 담아 12주동안 보관한 시료, 4℃로 일정하게 유지되는 완전히 차광된 냉장고 내에서 불투명 초자 용기에 담아 12주 동안 보관한 시료, -5℃에서 37℃를 순환하는 순환 챔버(1회/일)에 12주동안 보관한 시료에 대하여 분리, 변색 정도 및 침전 정도를 비교 측정하였다.Samples stored in an opaque vitreous container in a constant temperature bath maintained at 45 ° C. in Preparation Example 3, Comparative Examples 4 and 5 were stored for 12 weeks in an opaque glass container in a completely shaded refrigerator maintained at 4 ° C. The samples stored for 12 weeks, and samples stored for 12 weeks in a circulation chamber (once / day) circulating at 37 ° C. at −5 ° C. were compared and measured for the degree of discoloration and precipitation.

제품 분리 및 변색 정도를 다음의 6등급으로 분류하여 평가한 결과를 하기 표 8에 나타내었다.The results of the evaluation of product separation and discoloration graded into the following six grades are shown in Table 8.

제품 변색 평가 기준 :Product discoloration evaluation criteria:

0 : 변화 없음 1 : 극히 조금 분리(변색)0: no change 1: very little separation (discoloration)

2 : 조금 분리(변색) 3 : 조금 심하게 분리(변색)2: Slightly separated (discolored) 3: Slightly separated (discolored)

4 : 심하게 분리(변색) 5 : 극히 심하게 분리(변색)4: Extremely separated (discolored) 5: Extremely separated (discolored)

시험물질의 분리 및 변색 정도Separation and discoloration degree of test substance 온도Temperature 제조예 3Preparation Example 3 비교제조예 4Comparative Production Example 4 비교제조예 5Comparative Production Example 5 45℃45 ℃ 00 33 33 4℃4 ℃ 00 22 22 순환cycle 00 22 33

상기 표 8에 따르면, 동백나무 추출물이 나노리포좀을 통해 안정화된 제조예 3은 4℃, 45℃ 및 순환시험에서 변색이나 분리 증상이 없이 안정하였으나, 안정화시키지 않고 직접 제형에 사용한 비교 제조예 4 및 5의 경우에는 분리(변색)가 일어나 불안정함을 알 수 있었다.According to the Table 8, Preparation Example 3 stabilized Camellia extract through nanoliposomes is stable without discoloration or separation symptoms in 4 ℃, 45 ℃ and circulation test, Comparative Preparation Example 4 and used directly in the formulation without stabilization In case of 5, separation (discoloration) occurred and it was found to be unstable.

또한, 제품 침전 정도를 다음의 6등급으로 분류하여 평가한 결과를 하기 표 9에 나타내었다.In addition, the results obtained by classifying the product precipitation degree into the following six grades are shown in Table 9 below.

제품 변색 평가 기준 :Product discoloration evaluation criteria:

0 : 변화 없음 1 : 극히 조금 침전0: no change 1: very slight precipitation

2 : 조금 침전 3 : 조금 심하게 침전2: little precipitate 3: little precipitation

4 : 심하게 침전 5 : 극히 심하게 침전4: settling heavily 5: settling extremely severe

시험물질의 침전 정도Precipitation degree of test substance 온도Temperature 제조예 3Preparation Example 3 비교제조예 4Comparative Production Example 4 비교제조예 5Comparative Production Example 5 45℃45 ℃ 00 33 33 4℃4 ℃ 00 33 22 순환cycle 00 33 22

상기 표 9에 따르면, 본 발명에 따른 동백나무 추출물을 나노리포좀으로 안정화시킨 화장료는 침전이 생기지 않아, 안정화되었음을 알 수 있었다.According to Table 9, it was found that the cosmetics stabilized camellia extract according to the present invention with nanoliposomes did not precipitate, it was stabilized.

이와 같이 동백나무 추출물을 안정화 시키지 않고 첨가하면, 제형 내의 다른 약한 이온성 고분자들과 쉽게 반응하여 침전 및 변색이 일어난다. 그러나, 본 발명에서와 같이 동백나무 추출물을 나노리포좀으로 안정화시켜 제형에 적용하는 경우에는 동백나무 추출물이 과량 첨가되어도 침전 및 변색 반응이 최소화됨을 알 수 있다.As such, the Camellia extract is added without stabilization, causing easy reaction with other weak ionic polymers in the formulation, causing precipitation and discoloration. However, when the camellia extract is stabilized with nanoliposomes as in the present invention and applied to the formulation, it can be seen that precipitation and discoloration reaction are minimized even when the Camellia extract is added in excess.

(시험예 9)(Test Example 9)

나노입자의 크기별 경피흡수 측정Measurement of Transdermal Absorption by Size of Nanoparticles

화학결합에 의하여 형광물질을 부가시킨 PMMA 고분자를 이용하여 각각 50nm, 80nm, 120nm 및 500nm의 크기를 갖는 나노입자를 제조하고, 암컷 무모 기니아 피그의 피부에 도포한 후, 일정시간이 경과한 후 피부 단면을 잘라 경피 흡수된 나노입자에서 방출되는 형광을 측정하였다.Nanoparticles having sizes of 50 nm, 80 nm, 120 nm and 500 nm were prepared using PMMA polymers to which fluorescent substances were added by chemical bonding, and applied to the skin of female hairless guinea pigs. The cross section was cut to measure the fluorescence emitted from the percutaneously absorbed nanoparticles.

형광 PMMA 고분자 나노입자의 제조는 폴리메틸메타아크릴레이트-코-메타아크릴산 (메틸메타아크릴레이트와 메타크릴릭산의 몰비는 84:16)의 메타아크릴산의 카르복실기에 형광분자를 공유결합하게 하였다.Preparation of fluorescent PMMA polymer nanoparticles allowed the fluorescent molecules to be covalently bonded to the carboxyl group of methacrylic acid of polymethylmethacrylate-co-methacrylic acid (molar ratio of methylmethacrylate and methacrylic acid is 84:16).

그 제조법을 간략히 설명하면 다음과 같다.The preparation method is briefly described as follows.

34g의 폴리메틸메타아크릴레이트-코-메타아크릴산을 150㎖의 무수분 메틸렌클로라이드에 녹인 뒤, 132mg의 디시클로헥실카보디이미드와 74mg의 N-하이드록시숙신이미드를 첨가하여 카르복실기를 활성화시켰다. 1시간동안 교반한 뒤, 222mg의 플루오레신아민을 첨가하여 플루오레신아민의 1차 아민과 활성화된 카르복실기가 반응하여 아미드결합을 형성하게 함으로써, 고분자 사슬에 형광분자가 공유결합하게 하였다. 반응은 상온, 암실조건에서 5시간동안 진행시켰다. 반응 후 형성되는 부산물인 디사이클로헥실우레아를 0.45㎛ 나일론 필터를 통해 제거한 뒤, 디에틸에테르에 침전시켜 반응시약 및 미반응 잔류물들을 일차적으로 제거하였다. 이어서, 이를 과량의 3차 증류수에서 하루동안 방치하여 나머지 잔류물들을 제거한 뒤, 40도에서 진공오븐을 이용하여 건조하였다. 그 결과, 형광물질이 부가된 50nm, 80nm, 120nm, 500nm의 크기를 갖는 PMMA 나노입자를 제조하였다.After 34 g of polymethylmethacrylate-co-methacrylic acid was dissolved in 150 ml of anhydrous methylene chloride, 132 mg of dicyclohexylcarbodiimide and 74 mg of N-hydroxysuccinimide were added to activate the carboxyl group. After stirring for 1 hour, 222 mg of fluoresceamine was added to react the primary amine of the fluorescein amine with the activated carboxyl group to form an amide bond, thereby allowing the fluorescent molecules to be covalently bonded to the polymer chain. The reaction proceeded for 5 hours at room temperature and dark conditions. Dicyclohexyl urea, a by-product formed after the reaction, was removed through a 0.45 μm nylon filter and then precipitated in diethyl ether to remove the reaction reagents and unreacted residues. Subsequently, it was left in excess tertiary distilled water for one day to remove the remaining residues, and then dried using a vacuum oven at 40 degrees. As a result, PMMA nanoparticles having sizes of 50 nm, 80 nm, 120 nm, and 500 nm to which fluorescent materials were added were prepared.

크기별 나노입자 경피흡수시험을 위하여 8주령 암컷 무모 기니아 피그(strain IAF/ HA-hrBR)를 이용하였다. 기니아 피그의 복부부위의 피부를 절취하여 프란즈-타입 디퓨젼 셀(Franz-type diffusion cells(Lab Fine Instruments, Korea))에 장착하여 실험하였다. 프라즈-타입 디퓨젼 셀의 수용 용기(5㎖)에는 50 mM 인산염 완충액(pH 7.4, 0.1M NaCl)을 넣어주었다. 디퓨젼 셀은 32℃를 유지해주면서 600 rpm으로 혼합, 분산시켜주었으며, 각 크기별로 제조된 형광 PMMA나노입자가 10%(w/v) 분산된 용액 50㎕를 각각의 도너(donor) 용기에 넣어주었다. 미리 예정한 시간(평균 12시간)에 따라 흡수 확산시켜 주었으며, 흡수 확산이 일어나는 피부의 면적은 0.64 cm2가 되게 하였다. 나노입자의 흡수 확산이 끝난 후에는, 건조된 Kimwipes로 피부위에 남아있는 흡수되지 못한 나노입자를 씻어주고, 피부의 단면을 절개하여 피부단면에 흡수된 형광 PMMA나노입자의 분포를 측정하였다.Eight-week-old female hairless guinea pigs (strain IAF / HA-hrBR) were used for the nanoparticle transdermal absorption test by size. The skin of the abdominal region of the guinea pig was cut and mounted in Franz-type diffusion cells (Lab Fine Instruments, Korea). A 50 mM phosphate buffer (pH 7.4, 0.1 M NaCl) was added to the receiving vessel (5 ml) of the plasma-type diffusion cell. The diffusion cell was mixed and dispersed at 600 rpm while maintaining 32 ° C. 50 μl of a solution containing 10% (w / v) of fluorescent PMMA nanoparticles prepared for each size was placed in each donor container. gave. Absorption and diffusion were performed according to a predetermined time (average 12 hours), and the area of skin where absorption and diffusion occurred was 0.64 cm 2 . After the absorption and diffusion of nanoparticles was finished, the non-absorbed nanoparticles remaining on the skin were washed with dried Kimwipes, and the cross-section of the skin was cut to measure the distribution of fluorescent PMMA nanoparticles absorbed on the skin section.

나노입자의 피부내 분포측정 결과를 하기 표 10에 나타내었다.The intradermal distribution measurement results of the nanoparticles are shown in Table 10 below.

나노입자의 평균 크기Average size of nanoparticles 경피흡수 도달부위Percutaneous absorption area 50nm50 nm 35㎛35 μm 80nm80 nm 17㎛17 μm 120nm120 nm 12㎛12㎛ 500nm500 nm 7㎛7㎛

상기한 실험으로부터 나노입자의 경피흡수는 평균 입경에 크게 의존함을 확인할 수 있었다. 평균 직경 50nm정도의 크기를 가지는 나노입자는 표피를 통과하여, 진피층 상단까지 흡수, 확산됨을 확인할 수 있었다. 입자의 크기가 500nm를 초과하는 경우에는 나노입자는 피부표면에 머물게 되며, 더 이상 피부내부로의 흡수가 일어나지 않았다. 평균 직경 50nm 내외의 나노입자의 피부흡수는 피부의 세포간 지질 사이로 확산되어 들어가고, 고분자의 소수성은 이러한 경피흡수를 촉진해주는 효과가 있는 것으로 판단된다. 또한, 경피흡수가 잘 안되거나 불안정한 유효 활성성분을 평균 입경 50nm 내외의 나노입자에 포집시켜 주는 경우 고분자에 의한 피부내부로의 전달을 통하여 활성성분의 경피흡수 전달이 가능할 수 있다.From the above experiments, it was confirmed that the percutaneous absorption of the nanoparticles largely depends on the average particle diameter. Nanoparticles having an average diameter of about 50nm size was passed through the epidermis, it was confirmed that the absorption and diffusion to the top of the dermal layer. When the particle size exceeds 500 nm, the nanoparticles stay on the skin surface and no longer absorb into the skin. Skin absorption of nanoparticles with an average diameter of about 50 nm is diffused into the intercellular lipids of the skin, and the hydrophobicity of the polymer is thought to have an effect of promoting such transdermal absorption. In addition, when the active ingredient is poorly or unstable, and the active ingredient is trapped in the nanoparticles having an average particle diameter of about 50 nm, it may be possible to transmit the percutaneous absorption of the active ingredient through delivery into the skin by a polymer.

본 발명에 따르면, 초임계 추출법에 의해 카테친 등의 유효 성분의 함량이 극대화된 동백나무 추출물을 나노리포좀에 함유시킴으로써, 미백, 보습, 탄력 등의 노화방지효과가 뛰어나면서도, 안정성, 피부 투과율 및 사용감이 우수한 화장료 조성물을 얻을 수 있다.According to the present invention, by containing a camellia extract maximized in the content of active ingredients such as catechins in the nanoliposomes by the supercritical extraction method, while having excellent anti-aging effects such as whitening, moisturizing, elasticity, stability, skin transmittance and feeling of use This excellent cosmetic composition can be obtained.

Claims (3)

초임계 추출법에 의한 동백나무 추출물을 포함하는 나노리포좀을 화장료 조성물 총 중량에 대하여 0.1 ~ 20 중량% 함유하는 것을 특징으로 하는, 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물.A cosmetic composition comprising a nanoliposomal stabilized Camellia extract, characterized in that containing 0.1 to 20% by weight of the nanoliposome comprising the Camellia extract by the supercritical extraction method with respect to the total weight of the cosmetic composition. 제 1항에 있어서,The method of claim 1, 상기 나노리포좀은 인지질, 글루타치온, 폴리솔베이트 20, 에탄올로 구성되는 리포좀을 고압유화장치에 7회 통과시켜 얻는 것을 특징으로 하는, 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물.The nanoliposomes are obtained by passing a liposome consisting of phospholipid, glutathione, polysorbate 20, ethanol seven times through a high-pressure emulsifying apparatus, cosmetic composition containing the nano-liposomes stabilized camellia extract. 제 1항에 있어서,The method of claim 1, 상기 동백나무 추출물은 나노리포좀에 대하여 10 ~ 40 중량%로 포함되어 있는 것을 특징으로 하는, 동백나무 추출물을 안정화시킨 나노리포좀을 함유하는 화장료 조성물.The Camellia extract is characterized in that it is contained in 10 to 40% by weight relative to the nanoliposomes, cosmetic composition containing the nano-liposomes stabilized Camellia extract.
KR1020030033413A 2003-05-26 2003-05-26 Cosmetic composition containing camellia japonica extract stabilized with nanoliposome KR20040101709A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030033413A KR20040101709A (en) 2003-05-26 2003-05-26 Cosmetic composition containing camellia japonica extract stabilized with nanoliposome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030033413A KR20040101709A (en) 2003-05-26 2003-05-26 Cosmetic composition containing camellia japonica extract stabilized with nanoliposome

Publications (1)

Publication Number Publication Date
KR20040101709A true KR20040101709A (en) 2004-12-03

Family

ID=37378359

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030033413A KR20040101709A (en) 2003-05-26 2003-05-26 Cosmetic composition containing camellia japonica extract stabilized with nanoliposome

Country Status (1)

Country Link
KR (1) KR20040101709A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100752990B1 (en) * 2006-08-02 2007-08-30 주식회사 대웅 Compositions for preventing or treating skin diseases comprising nanoliposomes and natural extracts
KR100858628B1 (en) * 2006-12-29 2008-09-17 주식회사 코리아나화장품 Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome
KR100912140B1 (en) * 2007-11-07 2009-08-13 건국대학교 산학협력단 Anti-allergy composition comprising leaves extract of Camellia japonica L.
KR101028701B1 (en) * 2008-06-05 2011-04-14 스킨큐어(주) Cosmetic compostions comprising Camellia japonica stamen with pollen and its extract for improving skin
KR101408019B1 (en) * 2012-03-28 2014-06-18 태경환 A composition comprising fruit extract of Camellia japonica having antioxidant and whitening effect
KR101629863B1 (en) * 2015-11-06 2016-06-13 명일스크린테크(주) Cosmetic composition for moisturizing and anti-aging containing extracts of Viscum album, Chamaecyparis Obtusa, Quercus Robur and Camellia japonica Linne

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100752990B1 (en) * 2006-08-02 2007-08-30 주식회사 대웅 Compositions for preventing or treating skin diseases comprising nanoliposomes and natural extracts
KR100858628B1 (en) * 2006-12-29 2008-09-17 주식회사 코리아나화장품 Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome
KR100912140B1 (en) * 2007-11-07 2009-08-13 건국대학교 산학협력단 Anti-allergy composition comprising leaves extract of Camellia japonica L.
KR101028701B1 (en) * 2008-06-05 2011-04-14 스킨큐어(주) Cosmetic compostions comprising Camellia japonica stamen with pollen and its extract for improving skin
KR101408019B1 (en) * 2012-03-28 2014-06-18 태경환 A composition comprising fruit extract of Camellia japonica having antioxidant and whitening effect
KR101629863B1 (en) * 2015-11-06 2016-06-13 명일스크린테크(주) Cosmetic composition for moisturizing and anti-aging containing extracts of Viscum album, Chamaecyparis Obtusa, Quercus Robur and Camellia japonica Linne

Similar Documents

Publication Publication Date Title
KR100825450B1 (en) Skin anti-wrinkle cosmetics composition containing Forsythiae Fruit extract
JP5948374B2 (en) Method for producing cosmetic composition containing ginseng fruit agaric fermented liquid
KR100799991B1 (en) Cosmetic composition for wrinkle care
KR20040043192A (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
KR101574558B1 (en) Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts
KR102058445B1 (en) Cosmetics composition with Extract of Sparassis crispa Wulf. ex Fr.
KR100361433B1 (en) Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
KR100710657B1 (en) Whitening cosmetic composition containing dihydroquercetin
KR20110013812A (en) Cosmetic composition containing salicornia herbacea callus extracts and laminaria digitata extracts for improving skin wrinkle or enhancing skin elasticity
KR102184317B1 (en) A complex materials for antiwrinkle and skin whitening
KR101987421B1 (en) Cosmetic composition for improving antioxidation and skin wrinkle comprising bertholletia excelsa seed oil, plukenetia volubilis seed oil, mangifera indica extract and fragaria chiloensis extract
KR20040101709A (en) Cosmetic composition containing camellia japonica extract stabilized with nanoliposome
KR100545044B1 (en) Cosmetics composition containing medicine herbs complex extract stabilized with nano-liposome
KR100903654B1 (en) Cosmetic compositions comprising Prunella Vulgaris extract and Adenosine
KR100882744B1 (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR20140013370A (en) Composition of skin external application containing lentinula edodes (berk.) sing. extract
KR100308178B1 (en) Skin wrinkle care composition containing chestnut bark extract
KR101361848B1 (en) Method for Preparing Mucin from Dioscorea opposita and Cosmetic Composition Containing the Same
KR102198589B1 (en) Whitening cosmetic composition containing Rhodiola rosea, Selaginella tamariscina, Celosia cristata and Artemisia princeps complex extract and phytol
KR100512691B1 (en) Cosmetic composition containing salvia miltorrhiza bunge extract stabilized with nanoliposome
KR20080098925A (en) Cometic compositions containing extract of paeonia suffruticosa andrew
KR20220102236A (en) A cosmetic composition for blocking fine dust and anti-aging
KR20170137560A (en) Composition for improving skin condition comprising herb extracts mixture
JPH11171784A (en) External preparation for skin
KR100552269B1 (en) A cosmetic composition containing extract of Campsis grandiflora and/or Torreya nucifera seed

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application